Inhibition of nemo-like kinase increases taxol sensitivity in laryngeal cancer

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7137-7141

  Dong, Ji Rui ^a   Guo, Nan ^a   Zhao, Jian Pu ^a   Liu, Pin Duo ^a   Feng, Hui Hong ^a   Li, Yan ^a  

^a BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Hep 2 cells; Laryngeal cancer; Nemo like kinase; Sensitivity; Taxol

Indexed keywords

ANTINEOPLASTIC AGENT; MESSENGER RNA; NLK PROTEIN, HUMAN; PACLITAXEL; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; SMALL INTERFERING RNA;

ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; FLOW CYTOMETRY; GENETICS; HUMAN; LARYNGEAL NEOPLASMS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LARYNGEAL NEOPLASMS; PACLITAXEL; PROTEIN-SERINE-THREONINE KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR CELLS, CULTURED;

EID: 84893349999     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7137     Document Type: Article

References (23)

1. Brott BK, Pinsky BA, Erikson RL (1998). Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus. Proc Natl Acad Sci USA, 95, 963-8.
2. Cui G, Li Z, Shao B, et al (2011). Clinical and biological significance of nemo-like kinase expression in glioma. J Clin Neurosci, 18, 271-5.
3. Essers J, Theil AF, Baldeyron C, et al (2005). Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol, 25, 9350-59.
4. Emami KH, Brown LG, Pitts TE, et al (2009). Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells. Prostate, 69, 1481-92.
5. Hershko A (1999). Mechanisms and regulation of the degradation of cyclin B. Philos Trans R Soc Lond B Biol Sci, 354, 1571-5.
6. Harada H, Yoshida S, Nobe Y, et al (2002). Genomic structure of the human NLK (nemo-like kinase) gene and analysis of its promoter region. Gene, 285, 175-82.
7. Ishitani T, Ninomiya-Tsuji J, Nagai S, et al (1999). The TAK1-NLK-MAPK-related pathway antagonizes signalling between beta-catenin and transcription factor TCF. Nature, 399, 798-802.
8. Ito M (2000). Factors controlling cyclin B expression. Plant Mol Biol, 43, 677-90.
9. Jung KH, Kim JK, Noh JH, et al (2010). Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma. J Cell Biochem, 110, 687-96.
10. Kim M, Lee HC, Tsedensodnom O, et al (2008). Functional interaction between Wnt3 and Frizzled-7 leads to activation of the Wnt/beta-catenin signaling pathway in hepatocellular carcinoma cells. J Hepatol, 48, 780-91.
11. Lazebnik YA, Kaufmann SH, Desnoyers S, et al (1994). Cleavage of poly (ADP-ribose) polymerase by a proteinase with properties like ICE. Nature, 371, 346-7, 1994.
12. Lee JY, Marston DJ, Walston T (2006). Wnt/Frizzled signaling controls C. elegans gastrulation by activating actomyosin contractility. Curr Biol, 16, 1986-97.
13. Nicholson DW, Ali A, Thornberry NA, et al (1995). Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature, 376, 37-43.
14. Nestle FO, Alijagic S, Gilliet M, et al (1998). Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nat Med, 4, 328-32.
15. Satoh MS and Lindahl T (1992). Role of poly (ADP-ribose) formation in DNA repair. Nature, 356, 356-8.
16. Shivji KK, Kenny MK and Wood RD (1992). Proliferating cell nuclear antigen is required for DNA excision repair. Cell, 69, 367-74.
17. Sanderson RJ and Ironside JA (2002). Squamous cell carcinomas of the head and neck. BMJ, 325, 822-7.
18. Stevens KN, Kelemen LE, Wang X, et al (2012). Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 21, 523-8.
19. Tewari M, Quan LT, O'Rourke K, et al (1995). Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell, 81, 801-9.
20. Yasuda J, Tsuchiya A, Yamada T (2003). Nemo-like kinase induces apoptosis in DLD-1 human colon cancer cells. Biochem Biophys Res Commun, 308, 227-33.
21. Yuzugullu H, Benhaj K, Ozturk N, et al (2009). Canonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells. Mol Cancer, 8, 90.
22. Zhang Y, Peng C, Wu G, et al (2011). Expression of NLK and its potential effect in ovarian cancer chemotherapy. Int J Gynecol Cancer, 21, 1380-7.
23. Zhang X, Li W, Li H, et al (2012). Genomic methylation profiling combined with gene expression microarray reveals the aberrant methylation mechanism involved in nasopharyngeal carcinoma taxol resistance. Anticancer Drugs, 23, 856-64.